Literature DB >> 11929751

IRTAs: a new family of immunoglobulinlike receptors differentially expressed in B cells.

Ira Miller1, Georgia Hatzivassiliou, Giorgio Cattoretti, Cathy Mendelsohn, Riccardo Dalla-Favera.   

Abstract

The IRTA1 and IRTA2 genes encode immunoglobulinlike cell surface receptors expressed in B cells and involved in chromosome 1q21 translocations in B-cell malignancy. We have now characterized and comparatively analyzed the structure and expression pattern of the entire family of IRTA genes, which includes 5 members contiguously located on chromosome 1q21. The IRTA messenger RNAs are expressed predominantly in the B-cell lineage within discrete B-cell compartments: IRTA1 is specific to the marginal zone, IRTA2 and IRTA3 are found in the germinal center light zone and in intraepithelial and interfollicular regions, and IRTA4 and IRTA5 are expressed predominantly in the mantle zone. All IRTA genes code for transmembrane receptors that are closely related to Fc receptors in their most amino-terminal extracellular domains and that possess cytoplasmic domains containing ITIM (immunotyrosine inhibition motifs)- and, possibly, ITAM (immunotyrosine activation motifs)-like motifs. These structural features suggest that the IRTA receptors may play a role in regulating activation of normal B cells and possibly in the development of neoplasia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11929751     DOI: 10.1182/blood.v99.8.2662

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  32 in total

1.  Endothelial cell SHP-2 negatively regulates neutrophil adhesion and promotes transmigration by enhancing ICAM-1-VE-cadherin interaction.

Authors:  Meiping Yan; Xinhua Zhang; Ao Chen; Wei Gu; Jie Liu; Xiaojiao Ren; Jianping Zhang; Xiaoxiong Wu; Aaron T Place; Richard D Minshall; Guoquan Liu
Journal:  FASEB J       Date:  2017-07-12       Impact factor: 5.191

Review 2.  Emerging roles for the FCRL family members in lymphocyte biology and disease.

Authors:  F J Li; W J Won; E J Becker; J L Easlick; E M Tabengwa; R Li; M Shakhmatov; K Honjo; P D Burrows; R S Davis
Journal:  Curr Top Microbiol Immunol       Date:  2014       Impact factor: 4.291

3.  A functional variant in FCRL3, encoding Fc receptor-like 3, is associated with rheumatoid arthritis and several autoimmunities.

Authors:  Yuta Kochi; Ryo Yamada; Akari Suzuki; John B Harley; Senji Shirasawa; Tetsuji Sawada; Sang-Cheol Bae; Shinya Tokuhiro; Xiaotian Chang; Akihiro Sekine; Atsushi Takahashi; Tatsuhiko Tsunoda; Yozo Ohnishi; Kenneth M Kaufman; Changsoo Paul Kang; Changwon Kang; Shigeru Otsubo; Wako Yumura; Akio Mimori; Takao Koike; Yusuke Nakamura; Takehiko Sasazuki; Kazuhiko Yamamoto
Journal:  Nat Genet       Date:  2005-04-17       Impact factor: 38.330

4.  Ligation of human Fc receptor like-2 by monoclonal antibodies down-regulates B-cell receptor-mediated signalling.

Authors:  Mahdi Shabani; Ali Ahmad Bayat; Mahmood Jeddi-Tehrani; Hodjatallah Rabbani; Mohammad Hojjat-Farsangi; Cristina Ulivieri; Zahra Amirghofran; Cosima Tatiana Baldari; Fazel Shokri
Journal:  Immunology       Date:  2014-11       Impact factor: 7.397

5.  FCRLA is a resident endoplasmic reticulum protein that associates with intracellular Igs, IgM, IgG and IgA.

Authors:  Teresa Santiago; Sergei V Kulemzin; Evdokia S Reshetnikova; Nikolai A Chikaev; Olga Y Volkova; Ludmila V Mechetina; Meina Zhao; Randall S Davis; Alexander V Taranin; Alexander M Najakshin; Linda M Hendershot; Peter D Burrows
Journal:  Int Immunol       Date:  2010-12-13       Impact factor: 4.823

6.  An aberrant NOTCH2-BCR signaling axis in B cells from patients with chronic GVHD.

Authors:  Jonathan C Poe; Wei Jia; Hsuan Su; Sarah Anand; Jeremy J Rose; Prasanthi V Tata; Amy N Suthers; Corbin D Jones; Pei Fen Kuan; Benjamin G Vincent; Jonathan S Serody; Mitchell E Horwitz; Vincent T Ho; Steven Z Pavletic; Frances T Hakim; Kouros Owzar; Dadong Zhang; Bruce R Blazar; Christian W Siebel; Nelson J Chao; Ivan Maillard; Stefanie Sarantopoulos
Journal:  Blood       Date:  2017-08-29       Impact factor: 22.113

7.  FCRL1 on chronic lymphocytic leukemia, hairy cell leukemia, and B-cell non-Hodgkin lymphoma as a target of immunotoxins.

Authors:  Xing Du; Satoshi Nagata; Tomoko Ise; Maryalice Stetler-Stevenson; Ira Pastan
Journal:  Blood       Date:  2007-09-25       Impact factor: 22.113

8.  Gene expression profiling reveals differences in microenvironment interaction between patients with chronic lymphocytic leukemia expressing high versus low ZAP70 mRNA.

Authors:  Basile Stamatopoulos; Benjamin Haibe-Kains; Carole Equeter; Nathalie Meuleman; Anne Sorée; Cécile De Bruyn; Delphine Hanosset; Dominique Bron; Philippe Martiat; Laurence Lagneaux
Journal:  Haematologica       Date:  2009-04-18       Impact factor: 9.941

9.  FCRL2 expression predicts IGHV mutation status and clinical progression in chronic lymphocytic leukemia.

Authors:  Fu Jun Li; Shouluan Ding; Jicun Pan; Mikhail A Shakhmatov; Elena Kashentseva; Jiongru Wu; Yufeng Li; Seng-jaw Soong; Nicholas Chiorazzi; Randall S Davis
Journal:  Blood       Date:  2008-02-26       Impact factor: 22.113

10.  The Myc-miR-17-92 axis amplifies B-cell receptor signaling via inhibition of ITIM proteins: a novel lymphomagenic feed-forward loop.

Authors:  James N Psathas; Patrick J Doonan; Pichai Raman; Bruce D Freedman; Andy J Minn; Andrei Thomas-Tikhonenko
Journal:  Blood       Date:  2013-10-29       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.